Torrence PF - Search Results

1

2',5'-Oligoadenylate-antisense chimeras cause RNase L to selectively degrade bcr/abl mRNA in chronic myelogenous leukemia cells.

Maran A, Waller CF, Paranjape JM, Li G, Xiao W, Zhang K, Kalaycio ME, Maitra RK, Lichtin AE, Brugger W, Torrence PF, Silverman RH. Maran A, et al. Among authors: torrence pf. Blood. 1998 Dec 1;92(11):4336-43. Blood. 1998. PMID: 9834240 Free article.

2

Catalytic cleavage of an RNA target by 2-5A antisense and RNase L.

Maitra RK, Li G, Xiao W, Dong B, Torrence PF, Silverman RH. Maitra RK, et al. Among authors: torrence pf. J Biol Chem. 1995 Jun 23;270(25):15071-5. doi: 10.1074/jbc.270.25.15071. J Biol Chem. 1995. PMID: 7797490 Free article.

3

Blockage of NF-kappa B signaling by selective ablation of an mRNA target by 2-5A antisense chimeras.

Maran A, Maitra RK, Kumar A, Dong B, Xiao W, Li G, Williams BR, Torrence PF, Silverman RH. Maran A, et al. Among authors: torrence pf. Science. 1994 Aug 5;265(5173):789-92. doi: 10.1126/science.7914032. Science. 1994. PMID: 7914032

4

Targeting RNA decay with 2',5' oligoadenylate-antisense in respiratory syncytial virus-infected cells.

Cirino NM, Li G, Xiao W, Torrence PF, Silverman RH. Cirino NM, et al. Among authors: torrence pf. Proc Natl Acad Sci U S A. 1997 Mar 4;94(5):1937-42. doi: 10.1073/pnas.94.5.1937. Proc Natl Acad Sci U S A. 1997. PMID: 9050883 Free PMC article.

5

Selective RNA cleavage by isolated RNase L activated with 2-5A antisense chimeric oligonucleotides.

Silverman RH, Dong B, Maitra RK, Player MR, Torrence PF. Silverman RH, et al. Among authors: torrence pf. Methods Enzymol. 2000;313:522-33. doi: 10.1016/s0076-6879(00)13033-2. Methods Enzymol. 2000. PMID: 10595377 No abstract available.

6

Intrinsic molecular activities of the interferon-induced 2-5A-dependent RNase.

Dong B, Xu L, Zhou A, Hassel BA, Lee X, Torrence PF, Silverman RH. Dong B, et al. Among authors: torrence pf. J Biol Chem. 1994 May 13;269(19):14153-8. J Biol Chem. 1994. PMID: 7514601 Free article.

7

Targeting RNA for degradation with a (2'-5')oligoadenylate-antisense chimera.

Torrence PF, Maitra RK, Lesiak K, Khamnei S, Zhou A, Silverman RH. Torrence PF, et al. Proc Natl Acad Sci U S A. 1993 Feb 15;90(4):1300-4. doi: 10.1073/pnas.90.4.1300. Proc Natl Acad Sci U S A. 1993. PMID: 7679499 Free PMC article.

8

Correlation of selective modifications to a 2',5'-oligoadenylate-3',5'-deoxyribonucleotide antisense chimera with affinity for the target nucleic acid and with ability to activate RNase L.

Xiao W, Li G, Maitra RK, Maran A, Silverman RH, Torrence PF. Xiao W, et al. Among authors: torrence pf. J Med Chem. 1997 Apr 11;40(8):1195-200. doi: 10.1021/jm960748l. J Med Chem. 1997. PMID: 9111293

9

Nuclease-resistant composite 2',5'-oligoadenylate-3', 5'-oligonucleotides for the targeted destruction of RNA: 2-5A-iso-antisense.

Xiao W, Li G, Player MR, Maitra RK, Waller CF, Silverman RH, Torrence PF. Xiao W, et al. Among authors: torrence pf. J Med Chem. 1998 Apr 23;41(9):1531-9. doi: 10.1021/jm970841p. J Med Chem. 1998. PMID: 9554886

10

Targeting RNase L to human immunodeficiency virus RNA with 2-5A-antisense.

Player MR, Maitra RK, Silverman RH, Torrence PF. Player MR, et al. Among authors: torrence pf. Antivir Chem Chemother. 1998 May;9(3):225-31. doi: 10.1177/095632029800900303. Antivir Chem Chemother. 1998. PMID: 9875401

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

170 results

Search Page

Filters